| VRTIX | VYSEX | VRTIX / VYSEX | |
| Total Expense Ratio | 0.07 | 0.82 | 9% |
| Annual Report Gross Expense Ratio | 0.07 | 0.82 | 9% |
| Fund Existence | 15 years | 12 years | - |
| Gain YTD | 6.766 | 3.579 | 189% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 5000000 | 1000000 | 500% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 13.9B | 162M | 8,580% |
| Annual Yield % from dividends | 1.18 | 1.65 | 72% |
| Returns for 1 year | -1.17 | -12.21 | 10% |
| Returns for 3 years | 28.36 | 18.77 | 151% |
| Returns for 5 years | 30.63 | -0.95 | -3,225% |
| Returns for 10 years | 105.94 | -12.59 | -841% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| BCSSX | 48.74 | 0.27 | +0.56% |
| Brown Capital Mgmt Small Co Instl | |||
| HEQFX | 4.93 | N/A | N/A |
| Monteagle Opportunity Equity Inv | |||
| BMGCX | 24.09 | N/A | N/A |
| BlackRock Mid-Cap Growth Equity Inv C | |||
| SSIPX | 14.53 | N/A | N/A |
| State Street International Stock Sel I | |||
| FIJYX | 42.63 | N/A | N/A |
| Fidelity Advisor Biotechnology Z | |||